InvestorsHub Logo
Followers 3
Posts 101
Boards Moderated 0
Alias Born 12/21/2020

Re: None

Sunday, 07/04/2021 11:00:41 AM

Sunday, July 04, 2021 11:00:41 AM

Post# of 1524
Found this on Investor Village: "Something doesn't look right. Panacea is not a public company. They had planned to become a public company, but that apparently fell through. On Dun & Bradstreet Panacea Life Sciences is listed as having 5 employees, and generates only approx. $550K REVENUE per year. They got a $7M loan in 2019. For this, Exactus is giving them 1,002,000 convertible preferred shares and 473,639,756 shares of Common Stock. How's that for dillution?

Could 22nd Century have found a way to unload bad debt by Panacea (a private company) in exchange for stock they can trade?

Exactus is going to change it's name to Panacea Life Sciences Holdings.

Exactus has a history of making bad decisions, failing, and changing their name. Oh, yeah, this 1:28 reverse split will not be their first.

"The past is prolog"....William Shakespeare (The Tempest)"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLSH News